By the same authors

Accounting for Timing when Assessing Health-Related Policies

Research output: Contribution to journalArticle

Standard

Accounting for Timing when Assessing Health-Related Policies. / Claxton, Karl; Asaria, Miqdad; Chansa, Collins; Jamison, Julian; Lomas, James; Ochalek, Jessica; Paulden, Mike.

In: Journal of Benefit-Cost Analysis, 26.01.2019.

Research output: Contribution to journalArticle

Harvard

Claxton, K, Asaria, M, Chansa, C, Jamison, J, Lomas, J, Ochalek, J & Paulden, M 2019, 'Accounting for Timing when Assessing Health-Related Policies', Journal of Benefit-Cost Analysis. https://doi.org/10.1017/bca.2018.29

APA

Claxton, K., Asaria, M., Chansa, C., Jamison, J., Lomas, J., Ochalek, J., & Paulden, M. (2019). Accounting for Timing when Assessing Health-Related Policies. Journal of Benefit-Cost Analysis. https://doi.org/10.1017/bca.2018.29

Vancouver

Claxton K, Asaria M, Chansa C, Jamison J, Lomas J, Ochalek J et al. Accounting for Timing when Assessing Health-Related Policies. Journal of Benefit-Cost Analysis. 2019 Jan 26. https://doi.org/10.1017/bca.2018.29

Author

Claxton, Karl ; Asaria, Miqdad ; Chansa, Collins ; Jamison, Julian ; Lomas, James ; Ochalek, Jessica ; Paulden, Mike. / Accounting for Timing when Assessing Health-Related Policies. In: Journal of Benefit-Cost Analysis. 2019.

Bibtex - Download

@article{13f9e7c928b24cc3a09fc96ffa802458,
title = "Accounting for Timing when Assessing Health-Related Policies",
abstract = "The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consumption effects avoids embedding multiple arguments in discounting policies. This helps to identify where parameters are likely to differ in particular contexts, what type of evidence would be relevant, what is currently known and how this evidence might be strengthened. The current evidence available to support the assessment of the key parameters is discussed and possible estimates and default assumptions are suggested. Reporting the results in an extensive way is recommended. This makes the assessments required explicit so the impact of alternative assumptions can be explored and analysis updated as better estimates evolve. Some projects will have effects across different countries where some or all of these parameters will differ. Therefore, the net present value of a project will be the sum of the country specific net present values rather than the sum of effects across countries discounted at some common rate.",
keywords = "I1, O1, O2, Health",
author = "Karl Claxton and Miqdad Asaria and Collins Chansa and Julian Jamison and James Lomas and Jessica Ochalek and Mike Paulden",
note = "{\circledC} Society for Benefit-Cost Analysis, 2019",
year = "2019",
month = "1",
day = "26",
doi = "10.1017/bca.2018.29",
language = "English",
journal = "Journal of Benefit-Cost Analysis",
issn = "2194-5888",
publisher = "Cambridge University Press",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Accounting for Timing when Assessing Health-Related Policies

AU - Claxton, Karl

AU - Asaria, Miqdad

AU - Chansa, Collins

AU - Jamison, Julian

AU - Lomas, James

AU - Ochalek, Jessica

AU - Paulden, Mike

N1 - © Society for Benefit-Cost Analysis, 2019

PY - 2019/1/26

Y1 - 2019/1/26

N2 - The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consumption effects avoids embedding multiple arguments in discounting policies. This helps to identify where parameters are likely to differ in particular contexts, what type of evidence would be relevant, what is currently known and how this evidence might be strengthened. The current evidence available to support the assessment of the key parameters is discussed and possible estimates and default assumptions are suggested. Reporting the results in an extensive way is recommended. This makes the assessments required explicit so the impact of alternative assumptions can be explored and analysis updated as better estimates evolve. Some projects will have effects across different countries where some or all of these parameters will differ. Therefore, the net present value of a project will be the sum of the country specific net present values rather than the sum of effects across countries discounted at some common rate.

AB - The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consumption effects avoids embedding multiple arguments in discounting policies. This helps to identify where parameters are likely to differ in particular contexts, what type of evidence would be relevant, what is currently known and how this evidence might be strengthened. The current evidence available to support the assessment of the key parameters is discussed and possible estimates and default assumptions are suggested. Reporting the results in an extensive way is recommended. This makes the assessments required explicit so the impact of alternative assumptions can be explored and analysis updated as better estimates evolve. Some projects will have effects across different countries where some or all of these parameters will differ. Therefore, the net present value of a project will be the sum of the country specific net present values rather than the sum of effects across countries discounted at some common rate.

KW - I1

KW - O1

KW - O2

KW - Health

U2 - 10.1017/bca.2018.29

DO - 10.1017/bca.2018.29

M3 - Article

JO - Journal of Benefit-Cost Analysis

T2 - Journal of Benefit-Cost Analysis

JF - Journal of Benefit-Cost Analysis

SN - 2194-5888

ER -